PB 7 of 2016
National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1)
National Health Act 1953
I, DIANNA PROSSER, Assistant Secretary (Acting), Pharmaceutical Policy Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 28 January 2016
DIANNA PROSSER
Assistant Secretary (Acting)
Pharmaceutical Policy Branch
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 1).
(2) This Determination may also be cited as PB 7 of 2016.
2 Commencement
This Determination commences on 1 February 2016.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Apixaban
Omit
Apomorphine
[2] Schedule 1, after item dealing with Rotigotine
Insert
Ruxolitinib
[3] Schedule 1, after item dealing with Vitamins, minerals and trace elements with carbohydrate
Omit
Voriconazole
[4] Schedule 2, after item dealing with Anastrozole
Insert
Apomorphine
[5] Schedule 2, after item dealing with Vinorelbine
Insert
Voriconazole